Inside 2026: The Industry’s AI Turning Point
January 7, 2026
The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.
6 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
FOYA: Celebrating Innovation in Pharma Facilities
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
Latest News
All the latest Medicine Maker articles.
New Approach Methodologies: Why the Future of Drug Development Must Be Human
December 18, 2025
NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?
3 min read
Promising Data For Off-the-Shelf Gene-edited Cell Therapy
December 17, 2025
New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia
2 min read
Bridging the Digital Divide: How Collaboration and Standardization Are Shaping the Future of Biotech
December 17, 2025
The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.
5 min read
This Week’s Biopharma News: New Pharma Legislation in Europe
December 16, 2025
Our latest news roundup reports on the oversubscribed financing for Cellular Origins, FDA approval for Amgen, CAR-T cell therapy outcomes, and more
5 min read
How Mixing FSP and FSO Models Bring Agility to Modern Clinical Development
December 15, 2025
Clinical trials are becoming longer, costlier and more complex, but a growing number of sponsors are finding agility in a hybrid approach.
4 min read
Scratching the Surface of Microneedle Array Patches
December 12, 2025
Why the industry should open its eyes to the benefits of microneedle array patches for drug delivery.
5 min read
Outsmarting Cancer: The “Trojan Horse” of Gene Therapy
December 11, 2025
Borrowing strategy from ancient Greece, Trogenix hides its therapeutic warriors inside tumor cells. CEO Ken Macnamara discusses how.
5 min read
Rebuilding Confidence in UK Pharma Manufacturing
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
This Week’s CGT News: Vertex’s Gene Therapies Show Promise in Younger Children
December 10, 2025
Our latest news roundup reports on new data for Vertex’s exa-cel, funding for a cell therapy for breast cancer, and new technologies for manufacturing
3 min read
DSCSA in Action: Real-World Lessons from US Supply Chain Implementation
December 9, 2025
After a decade of preparation, the US pharmaceutical supply chain has seamless, serialized traceability for every prescription drug. Here are my lessons learned during that process.
3 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.